In a comprehensive Genomic Press Viewpoint (review) article, researchers are shining a spotlight on a revolutionary approach to tackling neuroendocrine tumors (NETs), a rare but increasingly prevalent ...

Alpha DaRT alpha-particle therapy, key 2026 trial catalysts, cash/dilution risks, and M&A takeover potential. See more.

Alpha particle radioluminescence detection and imaging is an advanced optical technique that capitalises on the light emitted when alpha particles interact with air molecules. When alpha particles – ...

Researchers have developed a new type of tumor-targeted alpha-particle therapy that has the potential to generically treat several kinds of cancer, with fewer negative side effects than currently ...

Theoretical calculations predict a complex excited state (0+) for helium-4 (4He) at the 20.21 MeV energy level. This state involves a coupling of three cluster configurations: hydrogen-3 and a proton, ...

A schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mice that had ...

Alpha Tau Medical (NASDAQ:DRTS) provided investors with a series of clinical, regulatory and financial updates, highlighting ...